Receptor targeting of adeno-associated virus vectors (original) (raw)
Blacklow NR et al. Epidemiology of adenovirus-associated virus infection in a nursery population. Am J Epidemiol 1968; 88: 368–378. ArticleCASPubMed Google Scholar
Blacklow NR et al. A seroepidemiologic study of adenovirus-associated virus infection in infants and children. Am J Epidemiol 1971; 94: 359–366. ArticleCASPubMed Google Scholar
Blacklow NR . Adeno-associated virus of humans. In: Pettison J (eds.) Parvovirus Hum Dis 1988; 165–174.
Hermonat PL . The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus. Virology 1989; 172: 253–261. ArticleCASPubMed Google Scholar
Mayor HD, Houlditch GS, Mumford DM . Influence of adeno-associated satellite virus on adenovirus-induced tumours in hamsters. Nat New Biol 1973; 241: 44–46. ArticleCASPubMed Google Scholar
Khleif SN, Myers T, Carter BJ, Trempe JP . Inhibition of cellular transformation by the adeno-associated virus rep gene. Virology 1991; 181: 738–741. ArticleCASPubMed Google Scholar
Carter PJ, Samulski RJ . Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 2000; 6: 17–27. CASPubMed Google Scholar
Monahan PE, Samulski RJ . Adeno-associated virus vectors for gene therapy: more pros than cons? Mol Med Today 2000; 6: 433–440. ArticleCASPubMed Google Scholar
Tal J . Adeno-associated virus-based vectors in gene therapy. J Biomed Sci 2000; 7: 279–291. ArticleCASPubMed Google Scholar
Rivadeneira ED et al. Sites of recombinant adeno-associated virus integration. Int J Oncol 1998; 12: 805–810. CASPubMed Google Scholar
Balague C, Kalla M, Zhang WW . Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J Virol 1997; 71: 3299–3306. ArticleCASPubMedPubMed Central Google Scholar
Rabinowitz JE, Samulski RJ . Building a better vector: the manipulation of AAV virions. Virology 2000; 278: 301–308. ArticleCASPubMed Google Scholar
Hermonat PL et al. Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J Virol 1984; 51: 329–339. ArticleCASPubMedPubMed Central Google Scholar
Smuda JW, Carter BJ . Adeno-associated viruses having nonsense mutations in the capsid genes: growth in mammalian cells containing an inducible amber suppressor. Virology 1991; 184: 310–318. ArticleCASPubMed Google Scholar
Tratschin JD, Miller IL, Carter BJ . Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol 1984; 51: 611–619. ArticleCASPubMedPubMed Central Google Scholar
Wistuba A, Weger S, Kern A, Kleinschmidt JA . Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. J Virol 1995; 69: 5311–5319. ArticleCASPubMedPubMed Central Google Scholar
Hoque M et al. Nuclear transport of the major capsid protein is essential for adeno-associated virus capsid formation. J Virol 1999; 73: 7912–7915. ArticleCASPubMedPubMed Central Google Scholar
Ruffing M, Zentgraf H, Kleinschmidt JA . Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J Virol 1992; 66: 6922–6930. ArticleCASPubMedPubMed Central Google Scholar
Dubielzig R et al. Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes. J Virol 1999; 73: 8989–8998. ArticleCASPubMedPubMed Central Google Scholar
Summerford C, Bartlett JS, Samulski RJ . AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 1999; 5: 78–82. ArticleCASPubMed Google Scholar
Hermens WT et al. Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum Gene Ther 1999; 10: 1885–1891. ArticleCASPubMed Google Scholar
Girod A et al. Genetic capsid modifications allow efficient re-targeting of adeno- associated virus type 2. Nat Med 1999; 5: 1052–1056. ArticleCASPubMed Google Scholar
Grimm D, Kleinschmidt JA . Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum Gene Ther 1999; 10: 2445–2450. ArticleCASPubMed Google Scholar
Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224–2232. ArticleCASPubMedPubMed Central Google Scholar
Ferrari FK, Xiao X, McCarty D, Samulski RJ . New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors. Nat Med 1997; 3: 1295–1297. ArticleCASPubMed Google Scholar
Chiorini JA et al. High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum Gene Ther 1995; 6: 1531–1541. ArticleCASPubMed Google Scholar
Summerford C, Samulski RJ . Viral receptors and vector purification: new approaches for generating clinical-grade reagents. Nat Med 1999; 5: 587–588. ArticleCASPubMed Google Scholar
Zolotukhin S et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999; 6: 973–985. ArticleCASPubMed Google Scholar
Xie Q et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 10405–10410. ArticleCASPubMedPubMed Central Google Scholar
Kronenberg S, Kleinschmidt JA, Bottcher B . Electron cryo-microscopy and image reconstruction of adeno-associated virus type 2 empty capsids. EMBO Rep 2001; 2: 997–1002. ArticleCASPubMedPubMed Central Google Scholar
Tsao J et al. The three-dimensional structure of canine parvovirus and its functional implications. Science 1991; 251: 1456–1464. ArticleCASPubMed Google Scholar
Agbandje M et al. Structure determination of feline panleukopenia virus empty particles. Proteins 1993; 16: 155–171. ArticleCASPubMed Google Scholar
Agbandje-McKenna M et al. Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure 1998; 6: 1369–1381. ArticleCASPubMed Google Scholar
Agbandje M et al. The structure of human parvovirus B19 at 8 A resolution. Virology 1994; 203: 106–115. ArticleCASPubMed Google Scholar
Summerford C, Samulski RJ . Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438–1445. ArticleCASPubMedPubMed Central Google Scholar
Wu P et al. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol 2000; 74: 8635–8647. ArticleCASPubMedPubMed Central Google Scholar
Rabinowitz JE, Xiao W, Samulski RJ . Insertional mutagenesis of AAV2 capsid and the production of recombinant virus. Virology 1999; 265: 274–285. ArticleCASPubMed Google Scholar
Bartlett JS, Wilcher R, Samulski RJ . Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J Virol 2000; 74: 2777–2785. ArticleCASPubMedPubMed Central Google Scholar
Qing K et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 1999; 5: 71–77. ArticleCASPubMed Google Scholar
Sanlioglu S et al. Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J Virol 2000; 74: 9184–9196. ArticleCASPubMedPubMed Central Google Scholar
Marks B et al. GTPase activity of dynamin and resulting conformation change are essential for endocytosis. Nature 2001; 410: 231–235. ArticleCASPubMed Google Scholar
Sever S, Damke H, Schmid SL . Dynamin:GTP controls the formation of constricted coated pits, the rate limiting step in clathrin-mediated endocytosis. J Cell Biol 2000; 150: 1137–1148. ArticleCASPubMedPubMed Central Google Scholar
Douar AM, Poulard K, Stockholm D, Danos O . Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J Virol 2001; 75: 1824–1833. ArticleCASPubMedPubMed Central Google Scholar
Girod A et al. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J Gen Virol 2002; 83: 973–978. ArticleCASPubMed Google Scholar
Zadori Z et al. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell 2001; 1: 291–302. ArticleCASPubMed Google Scholar
Seisenberger G et al. Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. Science 2001; 294: 1929–1932. ArticleCASPubMed Google Scholar
Samulski RJ, Berns KI, Tan M, Muzyczka N . Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci USA 1982; 79: 2077–2081. ArticleCASPubMedPubMed Central Google Scholar
Chiorini JA et al. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol 1997; 71: 6823–6833. ArticleCASPubMedPubMed Central Google Scholar
Muramatsu S, Mizukami H, Young NS, Brown KE . Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology 1996; 221: 208–217. ArticleCASPubMed Google Scholar
Rutledge EA, Halbert CL, Russell DW . Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998; 72: 309–319. ArticleCASPubMedPubMed Central Google Scholar
Hildinger M et al. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol 2001; 75: 6199–6203. ArticleCASPubMedPubMed Central Google Scholar
Halbert CL et al. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000; 74: 1524–1532. ArticleCASPubMedPubMed Central Google Scholar
Kaludov N et al. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol 2001; 75: 6884–6893. ArticleCASPubMedPubMed Central Google Scholar
Bantel-Schaal U, Delius H, Schmidt R, zur Hausen H . Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol 1999; 73: 939–947. ArticleCASPubMedPubMed Central Google Scholar
Seiler M et al. AAV5 and AAV6 mediate gene transfer to human airway epithelia via different receptors. Mol. Ther. 2002; 5: S40, abstract No. 117.
Rabinowitz JE et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791–801. ArticleCASPubMedPubMed Central Google Scholar
Handa A et al. Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J Gen Virol 2000; 81: 2077–2084. ArticleCASPubMed Google Scholar
Zabner J et al. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol 2000; 74: 3852–3858. ArticleCASPubMedPubMed Central Google Scholar
Halbert CL, Allen JM, Miller AD . Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol 2001; 75: 6615–6624. ArticleCASPubMedPubMed Central Google Scholar
Davidson BL et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428–3432. ArticleCASPubMedPubMed Central Google Scholar
Cosset FL, Russell SJ . Targeting retrovirus entry. Gene Ther 1996; 3: 946–956. CASPubMed Google Scholar
Walter W, Stein U . Cell type specific and inducible promotors for vectors in gene therapy as an approach for cell targeting. J Mol Med 1996; 74: 379–392. Article Google Scholar
Grifman M et al. Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids. Mol Ther 2001; 3: 964–975. ArticleCASPubMed Google Scholar
Shi W, Arnold GS, Bartlett JS . Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Hum Gene Ther 2001; 12: 1697–1711. ArticleCASPubMed Google Scholar
Yang Q et al. Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy. Hum Gene Ther 1998; 9: 1929–1937. ArticleCASPubMed Google Scholar
Bartlett JS, Kleinschmidt J, Boucher RC, Samulski RJ . Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody. Nat Biotechnol 1999; 17: 181–186. ArticleCASPubMed Google Scholar
Nicklin SA et al. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. Mol Ther 2001; 4: 174–181. ArticleCASPubMed Google Scholar
Ried MU et al. Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors. J Virol 2002; 76: 4559–4566. ArticleCASPubMedPubMed Central Google Scholar
Ziady AG et al. Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor. Am J Physiol 1997; 273G: 545–552. Google Scholar
Chapman MS, Rossmann MG . Structure, sequence, and function correlations among parvoviruses. Virology 1993; 194: 491–508. ArticleCASPubMed Google Scholar
Weichert WS et al. Assaying for structural variation in the parvovirus capsid and its role in infection. Virology 1998; 250: 106–117. ArticleCASPubMed Google Scholar
Aumailley M et al. Identification of the Arg–Gly–Asp sequence in laminin A chain as a latent cell-binding site being exposed in fragment P1. FEBS Lett 1990; 262: 82–86. ArticleCASPubMed Google Scholar
Grimm D et al. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. Gene Ther 1999; 6: 1322–1330. ArticleCASPubMed Google Scholar
Ohno K et al. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat Biotechnol 1997; 15: 763–767. ArticleCASPubMed Google Scholar
Sinha P, Sengupta J, Ray PK . Functional mimicry of protein A of Staphylococcus aureus by a proteolytically cleaved fragment. Biochem Biophys Res Commun 1999; 260: 111–116. ArticleCASPubMed Google Scholar
Perabo L et al. In vitro evolution of receptor specific gene vectors: the adeno-associated virus display, submitted.